jump to content jump to footer

Categories:

Representatives of Mint Medical and Curagita shaking hands to mark their lung cancer screening partnership
Curagita and Mint Medical are building a quality- and data-secure infrastructure for the new lung cancer screening program together with 25 outpatient radiology screening sites and two second-read centers. Curagita's CuraHub and Mint Medical's mint Lesion software provide the technical foundation for structured reporting, second reads, and the integration of AI solutions such as contextflow's ADVANCE Chest CT.
Lung cancer screening: cooperation for efficient processes and digital networking
Heidelberg, September 15, 2026 – In close collaboration with two second-reader centers in Heidelberg and 25 outpatient radiology screening providers,…
Read more
Prof. Dr. Timm Denecke discusses AI-based early detection of liver cancer at RÖKO 2026
AI and MRI data may soon predict liver cancer risk before tumors form. Prof. Denecke explains the RACOON-MARDER project.
Predicting hepatocellular carcinoma (HCC) before it develops: Artificial Intelligence meets MRI
At RÖKO 2026, we spoke with Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, about RACOON-MARDER, a research project…
Read more
Portrait of Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust
Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust and Professor at the Institute of Cancer Research, discusses AI-powered whole-body MRI for multiple myeloma
AI-Powered Whole-Body MRI for Multiple Myeloma: Interview with Prof. Christina Messiou
Multiple myeloma poses a unique challenge for radiologists: the disease often affects the bone marrow unevenly, and conventional biopsies can only…
Read more
Portrait of Prof. Dr. Timm Denecke, Director of Radiology at Leipzig University Hospital, RÖKO 2026
The full RACOON-MARDER interview: how AI-driven analysis of MRI data could flag liver cancer risk before diagnosis.
RACOON-MARDER: AI Research for the Early Detection of Hepatocellular Carcinoma – Interview with Prof. Dr. Timm Denecke
Hepatocellular carcinoma (HCC, liver cancer) is one of the most common malignant tumors worldwide. Early detection and precise assessment of disease…
Read more
Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Read more
scroll-top